Samrat Pharmachem Profit & Loss Annual

BSE: 530125 | NSE: - | ISIN: INE103E01016 | Sector: Biotechnology & Drugs
356.00 -5.05 (-1.40%)Updated : 30 Jun 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Revenue 285.86281.58310.65221.81
Total Revenue 285.86281.58310.65221.81
Costof Revenue Total 266.75270.32277.87189.90
Gross Profit 19.1111.2632.7831.91
Selling/ General/ Admin Expenses Total 2.222.221.881.77
Depreciation/ Amortization 0.650.650.640.59
Other Operating Expenses Total 6.656.586.975.79
Total Operating Expense 276.27279.76287.36198.09
Operating Income 9.591.8223.2823.73
Interest Inc( Exp) Net- Non- Op Total -0.67-0.42-0.75-0.36
Other Net 0.971.120.000.23
Net Income Before Taxes 9.892.5222.5323.60
Provisionfor Income Taxes 2.770.365.906.42
Net Income After Taxes 7.112.1616.6317.18
Net Income Before Extra Items 7.112.1616.6317.18
Net Income 7.112.1616.6317.18
Income Availableto Com Excl Extra Ord 7.112.1616.6317.18
Income Availableto Com Incl Extra Ord 7.112.1616.6317.18
Diluted Net Income 7.112.1616.6317.18
Diluted Weighted Average Shares 0.310.310.310.31
Diluted EPS Excluding Extra Ord Items 23.027.0053.8355.62
DPS- Common Stock Primary Issue 1.001.001.00-
Diluted Normalized EPS 23.027.0053.8355.68
period Length 12.0012.0012.0012.00
period Type ----
Unusual Expense( Income) ---0.02
*All figures in crores except per share values
Recommended For You
Trending Stocks
871.80+14.05(1.64%)
2,054.35+11.45(0.56%)
1,199.40-25.80 (-2.11%)
2,163.10-44.90 (-2.03%)